It has been recently shown, however, that the acquisition of mesenchymal features by carcinoma cells may decrease their susceptibility to lysis by immune effector cells, including antigen-specific CD8+ T cells, innate natural killer (NK), and lymphokine-activated killer (LAK) cells (17, 18). Here, CD8A is linked to carcinoma.